We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock
PKBO

Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

42 hedge funds and large institutions have $43.7M invested in Peak Bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

14% more capital invested

Capital invested by funds: $38.4M → $43.7M (+$5.31M)

5% more funds holding

Funds holding: 40 → 42 (+2)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
42
Holders Change
+2
Holders Change %
+5%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CSS
Cubist Systematic Strategies
Connecticut
+$2.34M
2
WRBC
W.R. Berkley Corp
Connecticut
+$2.22M
3
MC
Meteora Capital
Florida
+$1.98M
4
YCM
Yakira Capital Management
Connecticut
+$493K
5
CCM
CAAS Capital Management
New York
+$248K

Top Sellers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
-$2.07M
2
Barclays
Barclays
United Kingdom
-$212K
3
CM
Cohanzick Management
New York
-$146K
4
RA
RiverPark Advisors
New York
-$134K
5
BCM
Basso Capital Management
Connecticut
-$19.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
26
CVI Holdings
Delaware
$457K +$20.2K +2,050 +5%
CM
27
Crestline Management
Texas
$451K – – –
PMAM
28
Picton Mahoney Asset Management
Ontario, Canada
$395K – – –
LCM
29
Landscape Capital Management
New Jersey
$369K +$986 +100 +0.3%
AA
30
AQR Arbitrage
Connecticut
$345K – – –
Goldman Sachs
31
Goldman Sachs
New York
$270K – – –
CCM
32
CAAS Capital Management
New York
$248K +$248K +25,152 New
Walleye Capital
33
Walleye Capital
New York
$209K – – –
RCM
34
Rivernorth Capital Management
Florida
$197K – – –
HF
35
HRT Financial
New York
$195K -$1.4K -142 -0.7%
OMC
36
Old Mission Capital
Illinois
$184K +$10.6K +1,078 +6%
Walleye Trading
37
Walleye Trading
New York
$158K – – –
CF
38
Cantor Fitzgerald
New York
$158K +$158K +16,034 New
Millennium Management
39
Millennium Management
New York
$149K – – –
Ohio Public Employees Retirement System (OPERS)
40
Ohio Public Employees Retirement System (OPERS)
Ohio
$30K – – –
UBS Group
41
UBS Group
Switzerland
$23K -$1.87K -190 -7%
TRCT
42
Tower Research Capital (TRC)
New York
$1K -$10 -1 -1%
Barclays
43
Barclays
United Kingdom
– -$212K -21,583 Closed
RA
44
RiverPark Advisors
New York
– -$134K -13,586 Closed
1
2

PKBO Hedge Fund Activity: Q2 2022 in Review

42 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q2 2022, worth a combined $43.7M — up 14% from $38.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new PKBO positions and 2 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Cubist Systematic Strategies, opening a new position worth an estimated $2.34M. The largest seller was Spartan Fund Management, cutting an estimated $2.07M.

  • 42 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q2 2022, up from 40 in Q1 2022.
  • Funds reported $43.7M of Peak Bio, Inc. Common Stock stock for Q2 2022, up 14% quarter-over-quarter.
  • 5 funds opened new Peak Bio, Inc. Common Stock positions in Q2 2022 and 2 closed out, a net change of +3 holders.
  • The largest Peak Bio, Inc. Common Stock buyer in Q2 2022 was Cubist Systematic Strategies, an estimated $2.34M added.
  • The largest Peak Bio, Inc. Common Stock seller in Q2 2022 was Spartan Fund Management, an estimated $2.07M sold.

Based on aggregated 13F filings for Q2 2022.